BSEM 8.29 (-1.89%)
US0906842002BiotechnologyBiotechnology

BioStem Technologies (BSEM) Financial Metrics

This table shows a selected set of financial data points of BioStem Technologies (BSEM). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 0000-0.8716.69M-3.71M-6.93M-7.86M239.41K
2022 -0.630-4.7434.1M-2.346.88M-165.91K-4.44M-7.19M772.14K
2021 -0.120-8.4112.15M-0.544.34M-152.29K-1.29M-1.45M340.33K
2020 -0.260-5.5713.31M-0.822.52M-581.57K-1.59M-2.39M100.7K
2019 -0.680-3.6523.13M-1.72.63M-979.38K-5.34M-6.34M140.74K
2018 -0.790-4.0430.66M-2.271.02M-3.86M-7.28M-7.59M1.18M
2017 0000-1.87313.45K-2.04M-4.63M-4.79M51.58K
2016 0000-1.4607.22K00-3.96M166.25K
2015 0000-1.41151.54K00-2.38M411.89K
2014 0000-0.1000-186.14K50.94K
2011 -31.57000-0.171.36M00-527.14K26.18K
2010 0000-0.11.26M00-238.28K26.68K
2009 0000-0.02233.11K00-64.59K169.04K
1999 000001.32M00-8.14M34.69K

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies